Monday, September 14, 2026

This American Mom Just Rewrote Olympic History — By Four-Hundredths of a Second

Elana Meyers Taylor wins gold in women's monobob at the 2026 Winter Olympics, becoming the most decorated female bobsledder in history.

Will Padres’ Go Woo Suk Be on The ’26-man Roster’ for The Opening Series?

Can Go Woo Suk of the San...

Unification Ministry Promotes Wonsan Tourism In Three Stages, Prepares Health And Medical Package For North

The Ministry of Unification plans to enhance inter-Korean relations through tourism, trade, and humanitarian cooperation by 2026.

Tag: drug

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Revolutionary Wireless Neural Implant: Remote Brain Control from the U.S. to Korea

South Korean researchers developed a wireless device to remotely control a brain implant, delivering drugs and precisely regulating neurons.

Unlocking Biosimilar Success: Key Insights from the WHO Workshop in Asia

The Korean Ministry of Food and Drug Safety collaborates with WHO to unify biosimilar review standards in the Asia-Pacific region.

Celltrion’s CT-P51: Will This Keytruda Biosimilar Disrupt the 44 Billion USD Cancer Drug Market?

Celltrion has applied for approval of its biosimilar CT-P51 for the global blockbuster immuno-oncology drug Keytruda (pembrolizumab).

SK Plasma launches Revolpac, expands rare blood disorder portfolio

SK Plasma launches 'Revolpak' for treating thrombocytopenia, expanding its portfolio in rare and severe blood disorders.

HyDIFFUZE™: The Game-Changer in Subcutaneous ADC Delivery for Cancer Treatment

Huons Lab patents a platform technology for ADC subcutaneous injections, enhancing stability and drug delivery efficiency in biopharmaceuticals.

South Korea Eases Phase 3 Trial Requirements for Biosimilars Following U.S. and EU… Early Data Becomes Key Battleground

South Korea's MFDS eases Phase 3 trial requirements for biosimilars, aligning with global trends, enhancing early comparability importance.

HLB’s Rivoceranib Drug Approval: What the FDA’s VAI Classification Means for Liver Cancer Treatment

HLB's Rivoceranib facility received a VAI classification from the FDA, indicating compliance with GMP standards, aiding drug approval progress.

HLB’s Liver Cancer Drug: FDA’s VAI Conclusion Sparks Hope for Approval

HLB's Rivoceranib facility passed FDA inspection, receiving VAI classification, moving towards new liver cancer drug approval.

Inventage Lab to present mRNA-LNP large-scale manufacturing platform at CRS 2026

Inventage Lab showcases its IVL-GeneFluidic® platform for mRNA lipid nanoparticles at CRS 2026, enhancing local manufacturing capabilities.

Global Standards for Stimulant Drug Dependence: What You Need to Know

The world's first international standards for evaluating dependence on stimulant drugs are set to be established by the Ministry of Food and Drug Safety.

2026’s Game-Changer: Inventage Lab’s BioFluidic Technology Revolutionizes Antibody Drug Administration

Inventage Lab's CEO emphasizes the importance of platform technology for drug delivery systems and open innovation in the pharmaceutical industry.

SK Chemicals and J2H Biotech Partner for Breakthrough MASH Treatment: What You Need to Know

SK Chemicals partners with J2H Biotech to develop J2H-1702, a treatment for metabolic-associated steatotic liver disease, enhancing drug pipeline.

Dong-A ST Eyes Early-Stage Licensing Deals as Key Growth Strategy, Says VP Oh Yoon-seok [BIO USA]

Dong-A ST aims for global expansion by licensing preclinical drug candidates, focusing on timely execution of R&D strategies by 2027.

Mexico Recognizes South Korea’s MFDS: What This Means for Drug Approvals

Mexico recognizes South Korea's MFDS as a reference authority, streamlining drug approvals and enhancing market access for Korean firms.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.